Stock listing
NASDAQ:OCAT Ocata Therapeutics Inc Stock
Follow Ocata Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:OCAT
$8.47 USD
Close on Feb 9, 2016 · No longer trades
- Lowest – highest close
- $1.00 – $700.00 USDSince Feb 17, 2005 · lowest Jul 28, 2008 · highest Feb 18, 2005
Delisted NASDAQ:OCAT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OCAT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ocata Therapeutics Inc on 6ix
- Decks
- 3 decks · latest Feb 9, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| BIO CEO Presentation (February 2015) | Conference | 32 slides | Feb 9, 2015 |
| IPO Roadshow (December 2014) | IPO roadshow | 32 slides | Dec 19, 2014 |
| Advanced Cell Technology — Investor Presentation (July 2007) | Investor deck | 55 slides | Jul 2, 2007 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Heffernan Other companies: enGene Therapeutics Inc. (Director · Since at least Jul 8, 2025); Avalo Therapeutics, Inc. (Chairman of the Board · Since at least Mar 25, 2025); Biohaven Ltd. (Director · Since at least Sep 28, 2022); Trevi Therapeutics, Inc. (Lead Independent Director · Since at least May 7, 2019); Synlogic Inc (Director · Dec 8, 2020 – Jun 22, 2023 · Past); Biohaven Pharmaceutical Holding Co Ltd (Director · Jan 31, 2020 – Oct 3, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 2, 2021 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 21, 2016 – Dec 12, 2018 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – Feb 10, 2025 · Past) | Director · Apr 11, 2012 – Feb 10, 2016 · Past |
| Robert Langer Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past) | Director · Oct 4, 2011 – Feb 10, 2016 · Past |
| Gregory D Perry Other companies: Kala Bio, Inc. (Director · Since at least Feb 28, 2018); Novelion Therapeutics Inc (See Remarks · Nov 29, 2016 – May 9, 2017 · Past); Aegerion Pharmaceuticals Inc (See Remarks · Jul 6, 2015 – May 9, 2016 · Past); Eleven Biotherapeutics Inc (Chief Financial and Business · Feb 5, 2014 – Feb 26, 2015 · Past); InVivo Therapeutics Holdings Corp (Interim CFO · Sep 30, 2013 – Dec 30, 2013 · Past); ImmunoGen Inc (Chief Financial Officer · Jan 9, 2009 – Sep 10, 2013 · Past) | Director · Dec 2, 2011 – Feb 10, 2016 · Past |
| Michael D West Other companies: Serina Therapeutics, Inc. (Chief Executive Officer · Nov 27, 2018 – Mar 11, 2023 · Past); Insight Molecular Diagnostics Inc. (Director · Dec 30, 2015 – Feb 16, 2016 · Past); Asterias Biotherapeutics Inc (VP of Technology Integration, Director · Feb 13, 2015 – Feb 13, 2015 · Past); Lineage Cell Therapeutics, Inc. (Co-Chief Executive Officer, Director · Dec 31, 2005 – Sep 17, 2018 · Past) | Director · Oct 9, 2007 – Oct 9, 2007 · Past |
| Alan G Walton Other companies: ACADIA Pharmaceuticals Inc. (Director · Jun 13, 2006 – Jun 12, 2009 · Past); Avalon Pharmaceuticals Inc (Director · Dec 26, 2005 – Jan 2, 2008 · Past); Alexandria Real Estate Equities, Inc. (Director · Jan 14, 2005 – Dec 30, 2011 · Past) | Director · Jan 26, 2006 – Jan 26, 2006 · Past |
| Edward H Myles Other companies: Scholar Rock Holding Corporation (COO & CFO · Nov 19, 2018 – Mar 10, 2025 · Past); AMAG Pharmaceuticals Inc (COO & CFO · Apr 11, 2016 – Mar 10, 2020 · Past); Pressure BioSciences, Inc. (Senior VP of Finance & CFO · Apr 3, 2006 – Sep 25, 2008 · Past) | COO & CFO · Jun 12, 2013 – Feb 10, 2016 · Past |
| Paul Wotton Other companies: Vericel Corporation (Director · Since at least Jan 6, 2015); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past); Antares Pharma Inc (President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past) | President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past |
| Brian Levy Other companies: Aerie Pharmaceuticals Inc. (Chief Medical Officer · Oct 25, 2013 – Feb 25, 2015 · Past); InSite Vision Inc (Director · Aug 15, 2011 – Nov 2, 2015 · Past) | Director · Aug 31, 2015 – Feb 10, 2016 · Past |
| Erkki Ruoslahti Other companies: Lisata Therapeutics, Inc. (Director · Sep 15, 2022 – Jan 9, 2023 · Past) | Director · Jan 26, 2006 – Mar 4, 2011 · Past |
| Pedro Huertas Other companies: Inozyme Pharma Inc (SVP, CMO · Jul 23, 2020 – Jan 13, 2021 · Past) | Chief Development Officer · Feb 5, 2007 – Sep 7, 2007 · Past |
All 17 people
| Person | Seat |
|---|---|
| Alan C Shapiro | Director · Jan 26, 2006 – Feb 10, 2016 · Past |
| Eddy Anglade | Chief Medical Officer · Jan 6, 2014 – Feb 10, 2016 · Past |
| Gary H Rabin | CEO & CFO, Director · Feb 4, 2010 – Apr 15, 2013 · Past |
| H Le Roux Jooste | SVP of Bus Development & CCO · Oct 14, 2014 – Feb 10, 2016 · Past |
| Jonathan Dinsmore | SVP, Clinical & Regulatory · Nov 1, 2007 – Feb 6, 2008 · Past |
| Robert Lanza | Chief Scientific Officer · Aug 17, 2006 – Feb 10, 2016 · Past |
| William M Caldwell | Chief Executive Officer, Director · Dec 8, 2006 – Nov 13, 2009 · Past |
Log in to ask 6ix AI your own questions about Ocata Therapeutics Inc.